Brain Neoplasms  >>  Xcytrin (motexafin gadolinum)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Xcytrin (motexafin gadolinum) / AbbVie
NCT00080054: A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas

Completed
1
24
US
Motexafin Gadolinium Injection
Pharmacyclics LLC.
Glioma, Glioblastoma, Astrocytoma, Oligodendroglioma, Brain Neoplasm
 
 

Download Options